Antisalmonella Activity and Modes of Action of Extracts, Fractions and Cerevisterol from Impatiens burtonii against Multi-Drug Resistant Salmonella
Aurelie Dahlia Yemeli Piankeu, Frank Wilson Tiatsop Kenmoe, Aimé Gabriel Fankam, Michel Noubom, Siméon Pierre Chegaing Fodouop, Rémy Bertrand Teponno, Léon Azefack Tapondjou, Donatien Gatsing
Microbiology Research Journal International · pp. 54–71 · Published 22 Jun 2024
10.9734/mrji/2024/v34i71458Abstract
Background: Typhoid fever is an endemic disease in developing countries, especially throughout Asia and Africa, which may lead to life-threatening conditions in the absence of adequate treatment. Objective: This study was aimed at determining the in vitro activity of the crude extracts, fractions and compounds of Impatiens burtonii against drug sensitive and multidrug-resistant Salmonella strains. Methods: Moreover, the modes of action of the most active compound, cerevisterol (1) were investigated on Salmonella TyphiATCC6539.The in vitro antisalmonella activity of the samples was evaluated by the broth microdilution method. Catalase Activity was done by measuring the high of the foam in the presence of hydrogen peroxide. Bacteriolysis, time kill-assay, nucleic acid and protein leakage potential of cerevisterol were carried out through spectrophotometric methods. Finally, time kill-assay and proton-ATPase pump activity were determined by bacterial count and pH measurement, respectively. Results: The In vitro antisalmonella activity revealed that the hydroethanolic 75% crude extract of Impatiens burtonii showed the highest antisalmonella activity, with minimal inhibitory concentration (MIC) ranging from 32 to 512 μg/mL. Among the fractions of that extract, the dichloromethane (DM) fraction exhibited the highest activity, with MIC ranging from 16 to 32 μg/mL. Cerevisterol (1) isolated from the DM extract was the most active compound (8 ≤ MIC≤ 128 μg/mL). This study showed that cerevisterol is bacteriostatic against Salmonella Typhi. Moreover, cerevisterol induced the release of the nucleotides, inhibited H+-ATPase proton pumps, and reduced the catalase activity of Salmonella Typhi ATCC6539. Conclusion: Finally, this study allowed to identify cerevisterol as a good candidate to tackle typhoid fever infections and mainly that caused by MDR (multidrug-resistant) strains.
Cited by 0
No indexed citations yet.
Related research
- Typhoid Fever: Azithromycin vs. Ceftriaxone for the Treatment of Mild to Moderate Cases in Children — shares topic coverage
- Malaria, Typhoid, and PCV Variations: A Cross-sectional Study in Akinima, Nigeria — shares topic coverage
- A Prevalence Study of Typhoid Fever in Taiz and Al-Hodiedahcities in Yemen — shares topic coverage
- Isolation of Fluoroquinolones Resistant Salmonella spp. from Stool Samples of Patients Attending General Hospital Minna and Ibrahim Badamasi Babangida Specialist Hospital, Minna, Nigeria — shares topic coverage
- Assessment of Probiotic in Aquaculture: Functional Changes and Impact on Fish Gut — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.